{"id":"https://openalex.org/W1976312485","doi":"https://doi.org/10.1016/j.jalz.2008.05.1387","title":"P2\u2010310: Exebryl\u20101: A novel small\u2010molecule drug that markedly reduces amyloid plaque load and improves memory, enters human clinical trials","display_name":"P2\u2010310: Exebryl\u20101: A novel small\u2010molecule drug that markedly reduces amyloid plaque load and improves memory, enters human clinical trials","publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W1976312485","doi":"https://doi.org/10.1016/j.jalz.2008.05.1387","mag":"1976312485"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2008.05.1387","doi":"https://doi.org/10.1016/j.jalz.2008.05.1387","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2008.05.1387","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019375169","display_name":"Alan D. Snow","orcid":"https://orcid.org/0000-0002-7333-3100","observed_orcids":["https://orcid.org/0000-0002-7333-3100"]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alan D. Snow","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074811293","display_name":"Joel A. Cummings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel A. Cummings","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085592378","display_name":"Thomas P. Lake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas P. Lake","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086980931","display_name":"Luke Esposito","orcid":"https://orcid.org/0000-0002-3565-9126","observed_orcids":["https://orcid.org/0000-0002-3565-9126"]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luke A. Esposito","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057834780","display_name":"F. Michael Hudson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Michael Hudson","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074267150","display_name":"Qubai Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qubai Hu","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109074941","display_name":"Judy A. Cam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy A. Cam","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027879205","display_name":"Jocelyn R. Aker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jocelyn R. Aker","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075235800","display_name":"Steve Runnels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134826","display_name":"ProteoTech (United States)","ror":"https://ror.org/03fz0tx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Runnels","raw_affiliation_strings":["ProteoTech Inc., Kirkland, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoTech Inc., Kirkland, WA, USA","institution_ids":["https://openalex.org/I4210134826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019375169"],"corresponding_institution_ids":["https://openalex.org/I4210134826"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.2256,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.62035583,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"4","issue":"4S_Part_14","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.6582055687904358},{"id":"https://openalex.org/C2778896982","wikidata":"https://www.wikidata.org/wiki/Q2033625","display_name":"Thioflavin","level":4,"score":0.6566780209541321},{"id":"https://openalex.org/C2779155187","wikidata":"https://www.wikidata.org/wiki/Q114391","display_name":"Congo red","level":3,"score":0.632631778717041},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.520876407623291},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.5175106525421143},{"id":"https://openalex.org/C2776156579","wikidata":"https://www.wikidata.org/wiki/Q417667","display_name":"Amyloid beta","level":3,"score":0.4997107982635498},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4936407804489136},{"id":"https://openalex.org/C4224716","wikidata":"https://www.wikidata.org/wiki/Q10859258","display_name":"Immunostaining","level":3,"score":0.4537929594516754},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42359888553619385},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4067510664463043},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3502447009086609},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.340210497379303},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27606648206710815},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.27472439408302307},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.11136704683303833},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150394285","wikidata":"https://www.wikidata.org/wiki/Q180254","display_name":"Adsorption","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2008.05.1387","doi":"https://doi.org/10.1016/j.jalz.2008.05.1387","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2008.05.1387","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019645370","https://openalex.org/W2750286013","https://openalex.org/W2055619045","https://openalex.org/W2004524184","https://openalex.org/W2024037324","https://openalex.org/W2586510846","https://openalex.org/W4404033606","https://openalex.org/W2341713216","https://openalex.org/W2726584158","https://openalex.org/W2040215621"],"abstract_inverted_index":{"ProteoTech":[0,286],"has":[1,277],"developed":[2],"a":[3,13,30,79,98,193,278,324,334],"unqiue":[4],"small":[5,31,325],"molecule":[6,32,326],"library":[7],"based":[8],"on":[9],"the":[10,20,104,293,296,301,314,338],"identification":[11],"of":[12,39,81,169,206,229,273,298,303,317,340],"pharmacophore":[14],"that":[15,43,241,252,329],"was":[16,62,173,214,233],"optimized":[17],"to":[18,211,237,244,292,322,332],"target":[19],"beta-amyloid":[21,54,183],"protein":[22,55,184],"deposits":[23],"in":[24,44,65,109,125,162,197,201,222],"Alzheimer's":[25,341],"disease":[26,342],"(AD).":[27],"Exebryl-1":[28,61,102,155,191,253,299,319],"represents":[29],"analog":[33],"derived":[34],"from":[35],"over":[36],"8":[37],"years":[38],"research":[40],"and":[41,52,57,78,91,107,121,182,275,282,343],"testing":[42],"older":[45],"APP":[46,82,136],"transgenic":[47,83,137],"animals":[48],"markedly":[49],"reduced":[50],"fibrillar":[51],"soluble":[53],"loads,":[56],"significantly":[58],"improves":[59,254],"memory.":[60],"tested":[63,240],"using":[64,175],"vitro":[66],"assays":[67],"(Thioflavin":[68],"T":[69],"fluorometry;":[70],"Congo":[71,179],"red":[72,180],"staining;":[73],"electron":[74],"microscopy;":[75],"CD":[76],"spectroscopy)":[77],"number":[80],"animal":[84],"models.":[85],"In":[86,131],"addition,":[87],"PK,":[88],"oral":[89,100,145,208],"bioavailability":[90],"safety/toxicity":[92],"studies":[93,250],"are":[94,242,311],"near":[95],"completion.":[96],"Following":[97],"single":[99,140],"dose,":[101],"penetrates":[103],"blood-brain":[105],"barrier":[106],"accumulates":[108],"brain":[110,126,170,198,223,230,267],"tissue":[111,127],"within":[112],"30":[113],"minutes,":[114],"reaching":[115],"peak":[116],"levels":[117],"at":[118,128,217],"4":[119],"hours":[120],"is":[122,287,320,330],"still":[123,215],"prominent":[124],"24":[129],"hours.":[130],"one":[132],"study,":[133],"14-month":[134],"old":[135],"mice":[138],"(V717F":[139],"mutation)":[141],"were":[142],"treated":[143],"by":[144,187,261,271],"gavage":[146],"for":[147,166,295,300,313,337],"6":[148,218],"months":[149,205,219],"(100\u2013200":[150],"mg/kg/day)":[151],"with":[152],"either":[153],"vehicle,":[154],"or":[156],"some":[157],"other":[158,238],"compounds":[159,239],"currently":[160,288],"used":[161],"human":[163,308],"clinical":[164,309],"trials":[165,310],"AD.":[167,305],"Quantation":[168],"amyloid":[171,199,224,246],"load":[172,200,225,232],"implemented":[174],"Thio":[176],"S":[177],"fluorescence,":[178],"staining":[181],"immunostaining,":[185],"followed":[186],"image":[188],"analysis.":[189],"Overall,":[190],"caused":[192],"significant":[194],"39\u201343%":[195],"reduction":[196,221,228,272],"cortex,":[202],"following":[203],"3":[204],"daily":[207],"treatment":[209,302,339],"compared":[210],"controls,":[212],"which":[213],"maintained":[216],"(30\u201341%":[220],"observed).":[226],"This":[227],"plaque":[231],"\u223c":[234],"2X":[235],"superior":[236],"believed":[243,331],"be":[245,333],"reducing":[247],"agents.":[248],"Other":[249],"demonstrated":[251,260],"short-term":[255],"memory":[256],"(spatial":[257],"acquisition":[258],"as":[259],"Morris":[262],"water":[263],"maze":[264],"testing),":[265],"reduces":[266],"inflammation":[268],"(as":[269],"determined":[270],"astrocytosis":[274],"microgliosis);":[276],"good":[279],"safety":[280],"profile,":[281],"reasonable":[283],"PK/oral":[284],"bioavailability.":[285],"submitting":[289],"an":[290],"IND":[291],"FDA":[294],"use":[297],"mild-to-moderate":[304],"Phase":[306],"I":[307],"scheduled":[312],"2nd":[315],"quarter":[316],"2008.":[318],"postulated":[321],"represent":[323],"disease-modifying":[327],"drug":[328],"new":[335],"breakthrough":[336],"related":[344],"disorders.":[345]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}